Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia].

Medicina clinica - 24 Dec 2020

Ulhaq Zulvikar Syambani, Soraya Gita Vita

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to C-Reactive Protein
Share to Clinical Trials as Topic
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Drug Treatment

Share to Interleukin-6

Share to Receptors, Interleukin-6

Share to Respiration, Artificial

Source

Open in PubMed Open full text

Identifiers

PMID: 32950258
DOI: 10.1016/j.medcli.2020.07.002
PMCID: PMC7351402

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia].PMID 32950258Read ↗

Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumoniaSemantic proximity Read ↗

Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian populationSemantic proximity Read ↗

Assessing the potential correlation of polymorphisms in the IL6R with relative IL6 elevation in severely ill COVID-19 patients'.Semantic proximity Read ↗

Interleukin-1 Beta rs16944 and rs1143634 and Interleukin-6 Receptor rs12083537 Single Nucleotide Polymorphisms as Potential Predictors of COVID-19 Severity.Semantic proximity Read ↗

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population.Semantic proximity Read ↗

Association of polymorphisms of IL-6 pathway genes ( <i>IL6, IL6R</i> and <i>IL6ST</i> ) with COVID-19 severity in an Amazonian populationSemantic proximity Read ↗

Genetic variants mimicking therapeutic inhibition of IL-6 receptor signaling and risk of COVID-19Semantic proximity Read ↗

Pathway-Based Mendelian Randomization for Pre-Infection IL-6 Levels Highlights Its Role in Coronavirus Disease.Semantic proximity Read ↗

Impact of IL-6 rs1800795 and rs1800796 polymorphisms on clinical outcomes of COVID-19: a study on severity of disease in Turkish population.Semantic proximity Read ↗

Tocilizumab treatment leads to early resolution of lymphopenia and myeloid dysregulation in patients hospitalized with COVID-19Semantic proximity Read ↗

Evaluation of the relationship between IL-6 gene single nucleotide polymorphisms and the severity of COVID-19 in an Iranian population.Semantic proximity Read ↗

Genetic inhibition of interleukin-6 receptor signaling and Covid-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.